Physician profile
Paul W Codjoe
NPI 1487790952
$38,917.48
in general payments reported to CMS, 2019-2025
36 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,204 · 2020: $168 · 2021: $4,747 · 2022: $3,778 · 2023: $8,479 · 2024: $7,100 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $8,424 · Consulting Fee: $4,500 · Education: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,666.94 |
| Food and Beverage | $8,424.23 |
| Consulting Fee | $4,500.00 |
| Education | $1,428.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14,767.67 | 2022-2025 | Journey II, Spatial Frame, Real Intelligence |
| Seapearl East, INC | $5,921.95 | 2019-2024 | |
| Stryker Corporation | $4,617.56 | 2021-2025 | Salvation, Blueprint Patient Specific Instrumentation, Gamma |
| Zimmer Biomet Holdings, INC. | $3,820.71 | 2019-2025 | Persona, Oxford, Identity |
| Corentec America INC | $2,527.87 | 2025 | Corentec |
| Ortho Development Corporation | $1,203.53 | 2023 | |
| Arthrex, INC. | $1,069.96 | 2023 | |
| Orthalign INC | $1,065.31 | 2019-2023 | Orthalign Plus |
| Wright Medical Technology, INC. | $398.79 | 2019-2020 | |
| Globus Medical, INC. | $393.14 | 2025 | Senza |
| Pacira Therapeutics, INC. | $369.94 | 2019-2021 | |
| Conformis, INC. | $314.62 | 2021 | |
| Trice Medical, INC. | $289.18 | 2019 | |
| Depuy Synthes Sales INC. | $283.05 | 2019-2023 | Na |
| Encore Medical, LP | $210.40 | 2021-2024 | Djo Surgical |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $210.29 | 2023-2025 | Dynasplint |
| Uoc USA INC | $195.44 | 2023-2024 | U2 Press-Fit, Resolve, Pixee, Psi, U2 Press-Fit and Ustar II |
| Intrinsic Therapeutics | $171.43 | 2025 | Barricaid Acd (Annular Closure Device) |
| Ferring Pharmaceuticals INC. | $136.68 | 2019-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $114.72 | 2024-2025 | |
| Ethicon US, LLC | $113.44 | 2021 | |
| Heraeus Medical, LLC. | $100.52 | 2023-2025 | Palacos |
| Bioventus LLC | $98.29 | 2020-2024 | Durolane |
| Boston Scientific Corporation | $97.78 | 2025 | Wavewriter Alpha Prime 16 |
| Horizon Therapeutics Plc | $70.02 | 2019-2022 | |
| Medacta USA, INC. | $67.88 | 2021 | |
| Avanos Medical | $48.32 | 2022-2024 | Trivisc Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $47.65 | 2024 | Iovera, Zilretta, Exparel |
| Integra Lifesciences Corporation | $36.65 | 2019 | |
| Heron Therapeutics, INC. | $34.57 | 2024-2025 | Zynrelef |
| Davol INC. | $31.27 | 2023 | Arista Ah Flexitip |
| Kowa Pharmaceuticals America, INC. | $28.76 | 2022-2023 | Seglentis |
| Vericel Corporation | $17.34 | 2019 | |
| Abbott Laboratories | $16.32 | 2024 | Proclaim |
| Sanofi-Aventis U.S. LLC | $13.85 | 2019 | |
| Fidia Pharma USA INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Codjoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.